Catalogs from U-genes
Fluorescent Dyes
With U-genes, you get access to a diverse range of fluorescent dye products, each designed to elevate the precision and efficacy of life science applications. The extensive product line includes UGO, UGA, conventional fluorescent dyes and quenchers. Employing advanced production techniques and rigorous quality control measures, U-genes guarantees a purity level exceeding 95%. The fluorescent dye products impress with unparalleled stability and a remarkable quantum yield through continuous optimization of the production processes. Released February 2025.
CPG Products
Unlocking expanded possibilites for solid-phase oligonucleotide synthesis, U-genes' CPG-nucleoside products redefine the landscape of nucleotide modification. With higher loading density, these CPG-nucleosides offer enhanced versatility in crafting oligonucleotide sequences. This elevated loading density ensures efficiency and flexibility in the synthesis process, empowering researchers with advanced tools for tailored oligonucleotide design and construction. Released February 2025.
Amidites and Labeled Nucleotides
Phosphoramidites, distinguished by their heightened reactivity towards nucleophiles, are pivotal in nucleoside modification. In these reactions, the NR2 moiety is seamlessly replaced by incoming nucleophiles. U-genes' nucleoside phosphoramidites undergo meticulous manufacturing and packaging, ensuring optimal performance on commercial oligonucleotide synthesizers. The purities of these products exceed an impressive 99% (HPLC) and the moisture content maintained at less than 0.3% (NMR). Released February 2025.
Modified Nucleotides and Linkers
Modified nucleosides/nucleotides serve as invaluable building blocks in the synthesis of DNA and RNA, introducing alterations that enhance the stability, functionality, and utility of these genetic materials. The strategic incorporation of modified nucleosides optimizes coding sequences, contributing to the suppression of the immune response to synthetic mRNA. This not only reduces toxicity but also improves the translation of the gene, aligning with the quest for precision in genetic engineering and therapeutic applications. Released February 2025.
Building Blocks of Nucleic Acid Drugs
As nucleic acid drugs emerge as innovative therapeutic avenues with immense potential for treating human diseases, the demand for their foundational building blocks is escalating. U-genes meets this demand by offering an extensive array of building blocks essential for siRNA, and ASO development. Their nucleic acid drug-related products boast a purity level of up to 98% (HPLC), with moisture content maintained at less than 0.3 (NMR). As pioneers in providing essential building blocks, U-genes contributes to the seamless progress of nucleic acid drug development, empowering researchers in their quest for groundbreaking therapeutic modalities. Released February 2025.
Product Catalog
U-genes operates as a comprehensive R&D and production service platform, catering to the global biomedical industry's evolving needs. Their primary focus lies in delivering cutting-edge solutions, with a product portfolio spanning from modified nucleosides and nucleotides, to nucleoside pharmaceutical intermediates and organic fluorescent dyes. Leveraging U-genes' profound knowledge and skills, the company also offers catalog compounds and custom synthetic products to meet customer need. Released February 2025.